Intensive blood pressure and cholesterol control therapies were not tied to lower risk of cognitive decline
(dailyRx News) Type 2 diabetes has been linked to dementia and cognitive decline in older adults. A recent study examined whether intensive blood pressure goals and fibrate therapy could help.
Type 2 diabetes is a condition in which the body becomes resistant to insulin, a natural substance that regulates blood sugar.
The researchers found in two study arms that intensive treatment goals for high blood pressure and adding a fibrate medication to statin treatment of high cholesterol did not prevent cognitive decline and brain volume loss in diabetes patients compared to standard treatment.
Read more from RxWiki HERE.
Posted in Industry News